pulseData Raises $16.5M from Bain Capital Private Equity and Two Bear Capital
Learn More
helping you deliver precise care at less cost
Slowing chronic disease takes more than just computing models. We work with you from data to care delivery to ensure insights are trusted and actionable.
Find undiagnosed and unaware disease sufferers
Drive precise interventions to eliminate bad events
Get better outcomes and cost savings
Find Undiagnosed and Unaware Disease Sufferers
Drive Precise Interventions to Eliminate Bad Events
Get Better Outcomes and Cost Savings
Contact us for A DEMO
Employer plans

We give you visibility into the impact and cost of kidney care at your company.

Identify undiagnosed patients with kidney disease and track their care to improve health outcomes and avoid large, unpredictable medical bills.

Learn more →

We understand the basic business of kidney care is being transformed.

Minimize the cost of care by knowing which members are high-risk and driving early intervention.

Learn more →
Kidney care providers

We do the data, you deliver the care.

Succeed in this shifting space by deploying precisely-targeted care delivery to the patients who need it most.  

"We see the partnership between Rogosin and pulseData as critical to our future. We believe the current CKD project is the beginning of many collaborative projects to come and we look forward to the continued growth and success of our relationship."

— Dr. Jeffrey Silberzweig, Chief Medical Officer of The Rogosin Institute

Learn more →
Value-based systems

We know who is at-risk.

We partner closely with your providers to reduce the burden of chronic disease across your population by letting them know exactly who is at risk of acute events and which of their care workflows are working.

Learn more →
pulseData Raises $16.5 Million in Series A Funding Led by Bain Capital Private Equity and Two Bear Capital
April 21, 2021

pulseData, a New York City-based healthcare data science company, focused on predictive algorithms for Chronic Kidney Disease and other chronic diseases, today announced $16.5 million in Series A funding led by Bain Capital Private Equity and Two Bear Capital, with participation from Alumni Ventures Group and existing investors.

Improving community health in Brooklyn by identifying underlying chronic conditions
January 15, 2021

pulseData is working at the forefront of community health to develop techniques to risk stratify individuals at the earliest stages of renal disease. This work is vital in improving care and lowering the risk of poor health outcomes. In partnership with Rise Up ENY, pulseData is applying its cutting edge risk stratification technology to transform the health care landscape in Brooklyn, New York. Communities in Brooklyn are some of the hardest hit by the COVID-19 pandemic due to the prevalence of chronic disease.

pulseData is presenting at ASN Kidney Week 2020 Reimagined
October 22, 2020

COVID-19 has affected the lives of both the patients and the practice of nephrology. Despite the disruptive challenges created from being at the epicenter of COVID-19 (New York, NY), The Rogosin Institute multidisciplinary care team has been continuing to provide top-notch quality care powered by the pulseData intelligence platform


These value-based care teams use pulseData software and prediction engines
Learn more about our collaborative approach →

Subscribe our posts

Thanks! Your subscription has been confirmed!
Oops! Something went wrong while submitting the form.